FDA
-
-
-
-
-
-
-
Niagen Bioscience names new senior director of global research
-
-
-
-
-
-
-
Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference
-
-
-
-
-
-
-
Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™
-
-
-
-
-
-
-
Niagen Bioscience Increases Share Repurchase Program to $20 Million
-
-
-
-
-
-
-
Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction
-
-
-
-
-
-
-
Niagen Bioscience acquires nicotinamide riboside patent portfolio
-
-
-
-
-
-
-
Niagen Bioscience raises 2025 sales growth outlook to 25%-30%
-
327,204 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

